Extrapolation for biosimilars

posted 24/10/2014

Regarding extrapolation* of indications for biosimilars, the European Medicines Agency (EMA) has stated that ‘if clinical similarity can be shown in a key in...

Biosimilar bevacizumab similar to Avastin in pr... Biosimilars/Research | Posted 24/10/2014
Changes to pharmaceutical policy during an econ... Generics/Research | Posted 24/10/2014
Norwegian study may be slowing adoption of bios... Biosimilars/News | Posted 24/10/2014
FDA names and shames firms for failing to pay g... Generics/General | Posted 24/10/2014
Generics firms carve their way to victory Generics/News | Posted 24/10/2014
India drops planned price caps on non-essential... Policies & Legislation | Posted 24/10/2014
Mobilization of stem cells by biosimilar Nivest... Biosimilars/Research | Posted 17/10/2014
Reference pricing and generics in Finland Generics/Research | Posted 17/10/2014
Stada in-licenses teriparatide biosimilar Biosimilars/News | Posted 17/10/2014
French generics association promotes biosimilars Conferences | Posted 17/10/2014
Canada bans imports from three API facilities i... Generics/General | Posted 17/10/2014
Implications of Canadian–European Trade Agreeme... Policies & Legislation | Posted 17/10/2014
Phase III study of biosimilar adalimumab meets... Biosimilars/Research | Posted 10/10/2014
Generics in Taiwan: urban–rural disparity Generics/Research | Posted 10/10/2014
Thirty years of generics in the US Generics/General | Posted 10/10/2014
Merck KGaA plans further investment in biosimilars Biosimilars/News | Posted 10/10/2014
India suffers HIV drug shortages Pharma News | Posted 10/10/2014
Epirus and Livzon collaborate on copy biologica... Biosimilars/News | Posted 10/10/2014
European initiatives to enhance losartan utiliz... Generics/Research | Posted 03/10/2014
Infliximab ‘similar biologic’ receives Indian a... Biosimilars/News | Posted 03/10/2014
Biosimilars of adalimumab Biosimilars/General | Posted 03/10/2014
Strides and Shasun merger aims to spread risk Pharma News | Posted 03/10/2014
Mylan starts phase III trials for biosimilar in... Biosimilars/News | Posted 03/10/2014
New indication for old generic combination drug Generics/News | Posted 03/10/2014
IAPO releases toolkit for biologicals and biosi... Biosimilars/General | Posted 03/10/2014
Call for action on labelling of biosimilars Biosimilars/General | Posted 26/09/2014
The ethics of generic immunosuppressive drugs Generics/Research | Posted 26/09/2014
Amgen starts phase III trial for biosimilar rit... Biosimilars/News | Posted 26/09/2014
Phase III trials for generic asthma inhaler and... Generics/News | Posted 26/09/2014
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 26/09/2014
Roche updates position on biosimilars Biosimilars/News | Posted 26/09/2014
Generics taskforce for Australia Generics/General | Posted 26/09/2014
Strategy for biosimilars in China Biosimilars/Research | Posted 26/09/2014
Biosimilars of trastuzumab Biosimilars/General | Posted 19/09/2014
Pegteograstim biological approved in South Korea Biosimilars/News | Posted 19/09/2014
FDA approvals for generic AIDs and testosterone... Generics/News | Posted 19/09/2014
Patient access to rituximab in emerging markets Biosimilars/Research | Posted 19/09/2014
Generics applications under review by EMA – Aug... Generics/General | Posted 19/09/2014
Biosimilars in emerging markets Reports | Posted 19/09/2014
Cipla and S&D Pharma make generics deal for... Pharma News | Posted 19/09/2014
Regulating the safety of biosimilars Biosimilars/Research | Posted 12/09/2014
FDA debuts purple book for biologicals and inte... Biosimilars/General | Posted 12/09/2014

Generics News Research General


Biosimilars News Research General